Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate
Launched by CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS · May 16, 2012
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the genetic factors that contribute to certain reproductive disorders and conditions like cleft lip and/or palate. Some of the conditions being studied include Kallmann syndrome, which affects the sense of smell and puberty, as well as polycystic ovarian syndrome and cleft lip/palate. By exploring these genetic connections, researchers hope to gain insights that could lead to better treatment options or preventive measures in the future.
If you or a family member have one of the conditions mentioned, such as hypogonadotropic hypogonadism or precocious puberty, you might be eligible to participate. The trial is currently open for recruitment and welcomes individuals of all ages and genders. Participants can expect to provide some personal and family medical history and may undergo genetic testing. However, people with certain health issues, such as acute illnesses or chronic drug use, will not be able to join. This study is an opportunity to contribute to important research that could improve understanding and care for these conditions.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria:(any of the following conditions)
- • hypogonadotropic hypogonadism
- • Kallmann syndrome
- • adult-onset hypogonadotropic hypogonadism
- • hypothalamic amenorrhea
- • polycystic ovarian syndrome
- • primary gonadal failure
- • precocious puberty
- • cleft lip/palate
- • family members of the above groups
- Exclusion Criteria:
- • acute illness/hospitalization
- • pituitary tumors
- • iron overload (hemochromatosis)
- • infiltrative diseases (sarcoidosis)
- • chronic alcohol abuse
- • illicit drug use
- • anabolic steroid abuse
About Centre Hospitalier Universitaire Vaudois
The Centre Hospitalier Universitaire Vaudois (CHUV) is a leading academic medical center located in Lausanne, Switzerland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHUV plays a pivotal role in translating scientific discoveries into transformative therapies, enhancing patient care across a diverse range of medical disciplines. With a multidisciplinary team of experts and state-of-the-art facilities, CHUV is dedicated to fostering collaboration and delivering high-quality evidence that informs clinical practice and policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lausanne, Vaud, Switzerland
Patients applied
Trial Officials
Nelly Pitteloud, M.D.
Principal Investigator
Centre Hositalier Universitaire Vaudois (CHUV)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials